Bantilan, Baby Boy L.
HRN: 21-34-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
05/02/2022
05/09/2022
IVTT
13.5mg
OD
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes